SCHEMBL6487230

SCHEMBL6487230

COC(=O)C(C(=O)OC)c1ccccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
CASP1 P29466 1/20 0.46
KMT2A Q03164 1/20 0.46
ABCB11 O95342 2/20 0.45
THRB P10828 1/20 0.45
NR1I2 O75469 1/20 0.45
CHRM2 P08172 1/20 0.45
ADRA2A P08913 1/20 0.45
CYP2B6 P20813 1/20 0.45
DRD1 P21728 1/20 0.45
HTR2A P28223 1/20 0.45
SLC6A4 P31645 1/20 0.45
CYP2C19 P33261 1/20 0.45
OPRM1 P35372 1/20 0.45
OPRK1 P41145 1/20 0.45
HTR2B P41595 1/20 0.45
KCNH2 Q12809 1/20 0.45
P2RY12 Q9H244 1/20 0.45
ADRB2 P07550 2/20 0.42
ADRB1 P08588 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5861445 0.85 CASP1 (0.59) ALDH1A1CASP1KMT2A
SCHEMBL31506886 0.83 CASP1 (0.56) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL3685278 0.83 CASP1 (0.56) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL29572218 0.83 CASP1 (0.56) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL31612955 0.83 CXCL8 (0.46) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL13403891 0.83 CXCL8 (0.46) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL3697021 0.83 CASP1 (0.45) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL22939 0.83 CASP1 (0.56) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL29572016 0.83 CASP1 (0.56) ALDH1A1CASP1KMT2AABCB11THRB
SCHEMBL253615 0.83 CASP1 (0.56) ALDH1A1CASP1KMT2AABCB11THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222173-A1 Triazolopyrimidines BAYER CROPSCIENCE AG (DE) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222173-A1 Triazolopyrimidines Q6ZSR9, FLT3, PADI1 ALDH1A1 398/4885CASP1 2901/4885KMT2A 981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.